NTRR
Neutra Corp. [NTRR] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
NTRR Stock Summary
In the News
NTRR Financial details
Company Rating
Sell
Market Cap
1.17M
Income
-473.83K
Revenue
17.4K
Book val./share
-0
Cash/share
0
Dividend
-
Dividend %
-
Employees
15
Optionable
No
Shortable
Yes
Earnings
14 Jul 2020
P/E
-1.54
Forward P/E
-
PEG
0.15
P/S
41.93
P/B
-0.78
P/C
-
P/FCF
-74.71
Quick Ratio
-
Current Ratio
0.02
Debt / Equity
-0.06
LT Debt / Equity
-0.06
-
-
EPS (TTM)
-0
EPS next Y
-
EPS next Q
-
EPS this Y
-100%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-69.69%
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
0%
Inst Trans
-0%
ROA
-1759%
ROE
56%
ROC
0.29%
Gross Margin
46%
Oper. Margin
-1457%
Profit Margin
-2724%
Payout
-2%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
2.0E-4-7.0E-4
52W High
-
52W Low
-
RSI
47.94
Rel Volume
0.21
Avg Volume
4.77M
Volume
1.02M
Perf Week
-14.29%
Perf Month
-25%
Perf Quarter
0%
Perf Half Y
-25%
-
-
-
-
Beta
3.21
-
-
Volatility
0%, 0%
Prev Close
-25%
Price
0.0003
Change
-25%
NTRR Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-01-31
| Metric | History | 2019-01-31 | 2020-01-31 | 2021-01-31 | 2022-01-31 | 2023-01-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0 | 0 | 0 | 0 | |
| Net income per share | -0.16 | 0 | 0 | -79.67 | 0 | |
| Operating cash flow per share | -0.03 | 0 | 0 | 0 | 0 | |
| Free cash flow per share | -0.03 | 0 | 0 | 0 | 0 | |
| Cash per share | 0.01 | 0 | 0 | 0 | 0 | |
| Book value per share | -0.07 | 0 | 0 | 0 | 0 | |
| Tangible book value per share | -0.07 | 0 | 0 | 0 | 0 | |
| Share holders equity per share | -0.07 | 0 | 0 | 0 | 0 | |
| Interest debt per share | 0.09 | 0 | 0 | 0 | 0 | |
| Market cap | 482.99K | 193.23K | 4.41M | 1.92M | 1.12M | |
| Enterprise value | 908.64K | 328.43K | 4.63M | 2.16M | 1.17M | |
| P/E ratio | -0.2 | -0.19 | -6.68 | 0 | -1.99 | |
| Price to sales ratio | 0 | 30.22 | 455.66 | 20.86 | 16.4 | |
| POCF ratio | -1.16 | -1.06 | -10.7 | -4.73 | -7.28 | |
| PFCF ratio | -1.16 | -1.06 | -7.25 | -4.31 | -7.28 | |
| P/B Ratio | -0.44 | -0.23 | -5.44 | -1.88 | -1.51 | |
| PTB ratio | -0.44 | -0.23 | -5.44 | -1.88 | -1.51 | |
| EV to sales | 0 | 51.36 | 478 | 23.46 | 17.17 | |
| Enterprise value over EBITDA | -0.53 | -0.83 | -10.34 | -4.36 | -2.8 | |
| EV to operating cash flow | -2.18 | -1.81 | -11.23 | -5.32 | -7.62 | |
| EV to free cash flow | -2.18 | -1.81 | -7.6 | -4.84 | -7.62 | |
| Earnings yield | -5.03 | -5.36 | -0.15 | -66.39K | -0.5 | |
| Free cash flow yield | -0.86 | -0.94 | -0.14 | -0.23 | -0.14 | |
| Debt to equity | -0.53 | -0.37 | -0.49 | -0.48 | -0.08 | |
| Debt to assets | 3.6 | 1.71 | 2.08 | 3.74 | 0.77 | |
| Net debt to EBITDA | -0.25 | -0.34 | -0.48 | -0.48 | -0.13 | |
| Current ratio | 0.13 | 0.18 | 0.02 | 0 | 0.03 | |
| Interest coverage | -2.37 | -1.16 | -3.93 | -9.63 | -4.8 | |
| Income quality | 0.17 | 0.26 | 0.77 | 0.64 | 0.27 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0.01 | |
| Payout ratio | 0 | 0 | 0 | 0 | -0.02 | |
| Sales general and administrative to revenue | 0 | 62.65 | 42.81 | 5.53 | 3.35 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0.48 | 0.1 | 0 | |
| Capex to revenue | 0 | 0 | -20.28 | -0.44 | 0 | |
| Capex to depreciation | 0 | 0 | -6.41 | -0.52 | 0 | |
| Stock based compensation to revenue | 0 | 14.06 | 0 | 0 | 0 | |
| Graham number | 0.52 | 0.02 | 0 | 1.07 | 0 | |
| ROIC | 4.29 | 1.09 | 1.41 | 220.34K | 0.44 | |
| Return on tangible assets | -14.85 | -5.68 | -3.46 | -973.37K | -7.47 | |
| Graham Net | -0.07 | 0 | 0 | 0 | 0 | |
| Working capital | -1.11M | -849.49K | -977K | -1.15M | -733.82K | |
| Tangible asset value | -1.11M | -849.49K | -811.18K | -1.02M | -738.62K | |
| Net current asset value | -1.11M | -849.49K | -977K | -1.15M | -787.98K | |
| Invested capital | -0.53 | -0.37 | -0.49 | -0.48 | -0.08 | |
| Average receivables | 0 | 0 | 12.5 | 12.5 | 0 | |
| Average payables | 458.48K | 434.55K | 418.55K | 476.56K | 521.76K | |
| Average inventory | 0 | 1.75K | 1.75K | 0 | 11.92K | |
| Days sales outstanding | 0 | 0 | 0.94 | 0 | 0 | |
| Days payables outstanding | 0 | 0 | 3.62K | 3.16K | 5.77K | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 266.25 | |
| Receivables turnover | 0 | 0 | 387.48 | 0 | 18690598.16B | |
| Payables turnover | 0 | 0 | 0.1 | 0.12 | 0.06 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 1.37 | |
| ROE | 2.2 | 1.22 | 0.81 | 124.58K | 0.76 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-10-31 for Q3
| Metric | History | 2022-10-31 | 2023-01-31 | 2023-04-30 | 2023-07-31 | 2023-10-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0 | 0 | 0 | 0 | |
| Net income per share | 0 | 0 | 0 | 0 | 0 | |
| Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Cash per share | 0 | 0 | 0 | 0 | 0 | |
| Book value per share | 0 | 0 | 0 | 0 | 0 | |
| Tangible book value per share | 0 | 0 | 0 | 0 | 0 | |
| Share holders equity per share | 0 | 0 | 0 | 0 | 0 | |
| Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
| Market cap | 1.61M | 1.37M | 1.02M | 1.46M | 875.37K | |
| Enterprise value | 1.9M | 1.42M | 1.07M | 1.51M | 928.83K | |
| P/E ratio | -4.92 | -1.25 | -3.54 | -5.08 | -3.98 | |
| Price to sales ratio | 68.87 | 231.76 | 174.36 | 337.33 | 667.71 | |
| POCF ratio | -69.34 | 906.67 | -115.35 | -728.02 | -1.98K | |
| PFCF ratio | -69.34 | 906.67 | -115.35 | -728.02 | -1.98K | |
| P/B Ratio | -1.34 | -1.86 | -1.26 | -1.66 | -0.94 | |
| PTB ratio | -1.34 | -1.86 | -1.26 | -1.66 | -0.94 | |
| EV to sales | 81.42 | 240.58 | 183.1 | 349.59 | 708.49 | |
| Enterprise value over EBITDA | -41.08 | -6.03 | -20.78 | -25.74 | -21.27 | |
| EV to operating cash flow | -81.98 | 941.16 | -121.12 | -754.48 | -2.1K | |
| EV to free cash flow | -81.98 | 941.16 | -121.12 | -754.48 | -2.1K | |
| Earnings yield | -0.05 | -0.2 | -0.07 | -0.05 | -0.06 | |
| Free cash flow yield | -0.01 | 0 | -0.01 | 0 | 0 | |
| Debt to equity | -0.24 | -0.08 | -0.07 | -0.07 | -0.06 | |
| Debt to assets | 3 | 0.77 | 1.06 | 1.56 | 2.14 | |
| Net debt to EBITDA | -6.33 | -0.22 | -0.99 | -0.9 | -1.22 | |
| Current ratio | 0.02 | 0.03 | 0.03 | 0.02 | 0.02 | |
| Interest coverage | -4.2 | -3.72 | -357.83 | -2.47K | -23.35 | |
| Income quality | 0.28 | -0.01 | 0.12 | 0.03 | 0.01 | |
| Dividend Yield | 0 | 0.01 | 0 | 0 | 0 | |
| Payout ratio | 0 | -0.04 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 1.99 | 6.93 | 8.69 | 13.37 | 33.17 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0 | 0 | 0 | 0 | 0 | |
| ROIC | 0.1 | 0.09 | 0.1 | 0.09 | 0.06 | |
| Return on tangible assets | -0.83 | -3.66 | -1.33 | -1.94 | -2.04 | |
| Graham Net | 0 | 0 | 0 | 0 | 0 | |
| Working capital | -1.22M | -733.82K | -784.69K | -843.49K | -889.43K | |
| Tangible asset value | -1.2M | -738.62K | -809.21K | -881.05K | -936.04K | |
| Net current asset value | -1.27M | -787.98K | -838.84K | -897.65K | -943.58K | |
| Invested capital | -0.24 | -0.08 | -0.07 | -0.07 | -0.06 | |
| Average receivables | 0 | 0 | 0 | 0 | 49 | |
| Average payables | 500.95K | 510.13K | 514.95K | 497K | 480.98K | |
| Average inventory | 25.96K | 25.33K | 22.59K | 20.27K | 18.91K | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 6.73 | |
| Days payables outstanding | 3.56K | 15.69K | 15.2K | 16.38K | 59.96K | |
| Days of inventory on hand | 189.87 | 723.82 | 631.96 | 654.25 | 2.32K | |
| Receivables turnover | 6427470.1B | 1627002.33B | 1605836.73B | 0 | 13.38 | |
| Payables turnover | 0.03 | 0.01 | 0.01 | 0.01 | 0 | |
| Inventory turnover | 0.47 | 0.12 | 0.14 | 0.14 | 0.04 | |
| ROE | 0.07 | 0.37 | 0.09 | 0.08 | 0.06 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
NTRR Frequently Asked Questions
What is Neutra Corp. stock symbol ?
Neutra Corp. is a US stock , located in Sugar land of Tx and trading under the symbol NTRR
What is Neutra Corp. stock quote today ?
Neutra Corp. stock price is $0.0003 today.
Is Neutra Corp. stock public?
Yes, Neutra Corp. is a publicly traded company.
Company Profile
- Volume Average 4.77M
- Market Capitalization 1.17M
- Employee 15
- CEO Mr. Sydney Jim
- Headquarters Sugar Land,TX,US
- IPO Date 2011-10-12
-
Website
https://neutrainc.com 
Neutra Corp. researches, develops, and provides hemp-based nutraceutical products. It offers CBD sports creams and other products. The company was incorporated in 2011 and is based in Sugar Land, Texas.
